Risk factors of atrial arrhythmia recurrence and impact on the benefit of oral anticoagulation discontinuation: insights from the ALONE-AF trial
In the ALONE-AF trial, discontinuation of oral anticoagulation (OAC) reduced the risk of the primary outcome (a composite of stroke, systemic embolism, and major bleeding) in patients without atrial arrhythmia recurrence after catheter ablation for atrial fibrillation (AF). This post-hoc analysis aimed to...